ascopubs.org

Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.

Progression-free survival in patients receiving first-line platinum-based therapy in Argentina: OCEANIA study. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does ...
EurekAlert!

Korea University Guro Hospital & National Cancer Center Ovarian Cancer research team investigation of ‘Utilizing ELIMination rate constant K (KELIM) In Predicting Ovarian ...

-Paving the way for realizing precision medicine tailored to individual patients. Prof. Hyun-Woong Cho from the Gynecological Cancer Center at Korea University Guro Hospital announced that ‘it may be ...